Zevra therapeutics to report 2023 fourth quarter and full year financial results on march 28, 2024

Celebration, fla., march 18, 2024 (globe newswire) -- zevra therapeutics, inc. (nasdaqgs: zvra) (zevra, or the company) a rare disease therapeutics company, today announced that it will host a conference call and live audio webcast on thursday, march 28, 2024, at 4:30 p.m. et, to review its corporate and financial results for the fourth quarter and full year 2023.
ZVRA Ratings Summary
ZVRA Quant Ranking